We are live on ! Find out more
IDXX icon

Idexx Laboratories

1,107 hedge funds and large institutions have $47.1B invested in Idexx Laboratories in 2021 Q4 according to their latest regulatory filings, with 152 funds opening new positions, 350 increasing their positions, 415 reducing their positions, and 86 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more first-time investments, than exits

New positions opened: 152 | Existing positions closed: 86

6% more funds holding in top 10

Funds holding in top 10: 3133 (+2)

6% more capital invested

Capital invested by funds: $44.5B → $47.1B (+$2.55B)

5% more funds holding

Funds holding: 1,0581,107 (+49)

0.42% more ownership

Funds ownership: 84.2%84.62% (+0.42%)

16% less repeat investments, than reductions

Existing positions increased: 350 | Existing positions reduced: 415

29% less call options, than puts

Call options by funds: $144M | Put options by funds: $203M

Holders
1,107
Holders Change
+49
Holders Change %
+4.63%
% of All Funds
17.04%
Holding in Top 10
33
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+6.45%
% of All Funds
0.51%
New
152
Increased
350
Reduced
415
Closed
86
Calls
$144M
Puts
$203M
Net Calls
-$59.4M
Net Calls Change
+$26.8M
Name Holding Trade Value Shares
Change
Change in
Stake
BCV
401
Banque Cantonale Vaudoise
Switzerland
$3.42M +$99.8K +159 +3%
AAMU
402
AEGON Asset Management (UK)
United Kingdom
$3.39M +$71.6K +114 +2%
NMERB
403
New Mexico Educational Retirement Board
New Mexico
$3.39M -$251K -400 -7%
Twin Tree Management
404
Twin Tree Management
Texas
$3.38M +$1.79M +2,846 +124%
NA
405
NewEdge Advisors
Louisiana
$3.37M +$116K +185 +4%
KRS
406
Kentucky Retirement Systems
Kentucky
$3.37M +$7.53K +12 +0.2%
CCM
407
Covington Capital Management
California
$3.35M +$220K +350 +7%
SWM
408
Spire Wealth Management
Virginia
$3.33M +$2.48M +3,953 +359%
PA
409
Paragon Advisors
Texas
$3.27M -$342K -545 -10%
MFM
410
MD Financial Management
Ontario, Canada
$3.26M +$425K +677 +16%
WGAM
411
Wilkinson Global Asset Management
New York
$3.24M -$524K -835 -15%
SLI
412
Sumitomo Life Insurance
Japan
$3.2M +$52.7K +84 +2%
MIC
413
Means Investment Company
Maine
$3.19M -$64.7K -103 -2%
PWM
414
Penobscot Wealth Management
Maine
$3.18M -$10.7K -17 -0.4%
CGH
415
Crossmark Global Holdings
Texas
$3.17M -$2.26M -3,600 -43%
TCM
416
Tributary Capital Management
Nebraska
$3.16M -$502K -800 -14%
KA
417
Kintegral Advisory
New York
$3.06M
Cambridge Investment Research Advisors
418
Cambridge Investment Research Advisors
Iowa
$2.97M +$262K +417 +10%
KeyBank National Association
419
KeyBank National Association
Ohio
$2.94M -$323K -515 -10%
IAIM
420
Industrial Alliance Investment Management
Quebec, Canada
$2.9M +$2.76M +4,403 New
CAPTRUST Financial Advisors
421
CAPTRUST Financial Advisors
North Carolina
$2.87M +$267K +425 +11%
SFI
422
Siemens Fonds Invest
Germany
$2.86M +$575K +916 +27%
GC
423
Grimes & Company
Massachusetts
$2.85M
UH
424
Unigestion Holding
Switzerland
$2.79M +$1.17M +1,865 +79%
PWP
425
Perfromance Wealth Partners
Illinois
$2.79M +$2.65M +4,229 New

IDXX Hedge Fund Activity: Q4 2021 in Review

1,107 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q4 2021, worth a combined $47.1B — up 5.7% from $44.5B a quarter earlier.

Buyers outnumbered sellers: 152 funds opened new IDXX positions and 86 closed out — a net gain of 66 holders — while 350 added to existing stakes and 415 trimmed.

The largest buyer was BlackRock, adding an estimated $186M. The largest seller was Ameriprise, cutting an estimated $123M.

  • 1,107 institutional investors held Idexx Laboratories (IDXX) as of Q4 2021, up from 1,058 in Q3 2021.
  • Funds reported $47.1B of Idexx Laboratories stock for Q4 2021, up 5.7% quarter-over-quarter.
  • 152 funds opened new Idexx Laboratories positions in Q4 2021 and 86 closed out, a net change of +66 holders.
  • The largest Idexx Laboratories buyer in Q4 2021 was BlackRock, an estimated $186M added.
  • The largest Idexx Laboratories seller in Q4 2021 was Ameriprise, an estimated $123M sold.

Based on aggregated 13F filings for Q4 2021.